Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2009 by Yonsei University.
Recruitment status was:  Enrolling by invitation
Sponsor:
Information provided by:
Yonsei University
ClinicalTrials.gov Identifier:
NCT00900653
First received: May 12, 2009
Last updated: May 29, 2009
Last verified: May 2009

May 12, 2009
May 29, 2009
May 2009
May 2010   (Final data collection date for primary outcome measure)
Incidence of urinary tract infection [ Time Frame: 6 months ]
Same as current
Complete list of historical versions of study NCT00900653 on ClinicalTrials.gov Archive Site
  • vaginal pH [ Time Frame: 6 months ]
  • lactobacillus colonization [ Time Frame: 6 months ]
Same as current
Not Provided
Not Provided
 
Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women
Low Dose Estriol With Lactobacilli (Gynoflor) Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized, Open, Parallel-Group Study
Recurrent urinary tract infections (UTI) are a problem for postmenopausal women. The aim of this trial is to evaluate the effectiveness of lactobacilli in combination with low dose estriol for preventing recurrent urinary tract infections in postmenopausal women.
Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Urinary Tract Infections
Drug: Gynoflor E (low dose estriol with lactobacillus)
The medication, in the form of one vaginal tablet, is administered in the evenings for 18 days
Other Name: Gynoflor E vaginal tablet
  • Experimental: Gynoflor
    Intervention: Drug: Gynoflor E (low dose estriol with lactobacillus)
  • No Intervention: Control
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
142
July 2010
May 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Postmenopausal woman
  • History of urinary tract infection
  • Agree to abstain from self-medication with antibiotics for UTI symptoms
  • Agree to abstain from the use of any other intra-vaginal product
  • Capable of providing informed consent

Exclusion Criteria:

  • Ovarian cancer, cervical cancer, breast cancer
  • Estrogen treatment within last 2 years
  • Vaginal bleeding
  • Antibiotic therapy fewer than three days prior to randomization visit
  • Known congenital urologic or gynecologic abnormalities
  • Indwelling urinary catheter
  • Thromboembolic disease
  • Uncompensated liver disease
  • Immunosuppressive drug within 60 days
Sexes Eligible for Study: Female
40 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT00900653
4-2009-0022
No
Not Provided
Not Provided
Not Provided
Jun Yong Choi, Yonsei University College of Medicine
Yonsei University
Not Provided
Not Provided
Yonsei University
May 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP